Stay updated on Mepo for EoE Clinical Trial

Sign up to get notified when there's something new on the Mepo for EoE Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Mepo for EoE Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    No Change Detected
  4. Check
    3 days ago
    No Change Detected
  5. Check
    4 days ago
    No Change Detected
  6. Check
    5 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage, indicating a shift in the dosage of mepolizumab from 300 mg to 100 mg for subjects initially randomized to placebo in a clinical trial for treating adults and adolescents with active Eosinophilic Esophagitis (EoE) and dysphagia-predominant symptoms.
    Difference
    0.1%
    Check dated 2024-06-06T14:35:56.000Z thumbnail image
  7. Check
    20 days ago
    Change Detected
    Summary
    The value 'Participation Criteria 6' has been updated to 'Participation Criteria Researchers look for people who fit a certain description, called eligibility criteria.' This change provides a more detailed explanation of eligibility criteria, including examples such as a person's general health condition or prior treatments.
    Difference
    36%
    Check dated 2024-05-22T21:11:30.000Z thumbnail image
  8. Check
    42 days ago
    Change Detected
    Difference
    0.9%
    Check dated 2024-04-30T22:47:43.000Z thumbnail image

Stay in the know with updates to Mepo for EoE Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Mepo for EoE Clinical Trial page.